Literature DB >> 15602719

Significant responses to platinum-based chemotherapy in renal medullary carcinoma.

John J Strouse1, Melissa Spevak, A Kyle Mack, Robert J Arceci, Donald Small, David M Loeb.   

Abstract

Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15602719     DOI： 10.1002/pbc.20292

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  19 in total

1.  Pediatric non-Wilms' renal tumors: a third world experience.

Authors:  Peter W Saula; G P Hadley
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

2.  Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil.

Authors:  Marina Cavalcanti Maroja Silvino; Camila Motta Venchiarutti Moniz; Gustavo Henrique Munhoz Piotto; Sheila Siqueira; Ariel Galapo Kann; Carlos Dzik
Journal:  Rare Tumors       Date:  2013-08-20

3.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

4.  Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases.

Authors:  Zhenshan Shi; Qian Zhuang; Ruixiong You; Yueming Li; Jian Li; Dairong Cao
Journal:  Oncol Lett       Date:  2015-11-09       Impact factor: 2.967

5.  Renal medullary carcinoma: unsuspected diagnosis at stone protocol CT.

Authors:  Amy Neville; Stephen F Hatem
Journal:  Emerg Radiol       Date:  2007-04-04

6.  Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.

Authors:  Amishi Y Shah; Jose A Karam; Gabriel G Malouf; Priya Rao; Zita D Lim; Eric Jonasch; Lianchun Xiao; Jianjun Gao; Ulka N Vaishampayan; Daniel Y Heng; Elizabeth R Plimack; Elizabeth A Guancial; Chunkit Fung; Stefanie R Lowas; Pheroze Tamboli; Kanishka Sircar; Surena F Matin; W Kimryn Rathmell; Christopher G Wood; Nizar M Tannir
Journal:  BJU Int       Date:  2016-12-09       Impact factor: 5.588

7.  Renal medullary carcinoma: a nearly fatal malignancy specifically affecting patients with a so-called benign condition.

Authors:  Yamila Goenaga-Vázquez; Gloria Colón; Nilka Barrios; María Correa
Journal:  CEN Case Rep       Date:  2018-02-02

Review 8.  The changing face of renal cell carcinoma pathology.

Authors:  Hakan Aydin; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

9.  Saudi Oncology Society clinical management guidelines for renal cell carcinoma.

Authors:  Shouki Bazarbashi; Khaled Al Othman; Mohammed Al Otaibi; Ashraf Abusamra; Danny Rabah; Ali Aljubran; Esam Murshid; Ibraheem Al Oraifi; Mohammed El-Naghi; Yasser Bahader; Hussein Soudy; Amjad Rehman
Journal:  Urol Ann       Date:  2011-03

10.  Response to radiation in renal medullary carcinoma.

Authors:  Alexandra M Walsh; John B Fiveash; Alyssa T Reddy; Gregory K Friedman
Journal:  Rare Tumors       Date:  2011-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.